Cargando…

Surrogate strains of human pathogens for field release

Surrogate microorganisms, in short surrogates, are an essential part of pathogen research. Compared to surrogates used in controlled laboratory environments, surrogates for field release are restricted by concerns about human and environmental safety. For field research of food-borne pathogens, stra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sangjin, Kim, Chang-Hwan, Jeong, Seong Tae, Lee, Sang Yup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972925/ https://www.ncbi.nlm.nih.gov/pubmed/28692329 http://dx.doi.org/10.1080/21655979.2017.1349044

Ejemplares similares

Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis
por: Park, Sangjin, et al.
Publicado: (2018)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

Debate: The slippery slope of surrogate outcomes
por: D'Agostino, Ralph B
Publicado: (2000)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

Is critical care ready for an economic surrogate endpoint?
por: Wilcox, M Elizabeth, et al.
Publicado: (2015)

Establishment of the 3rd national standard for lot release testing of the Japanese encephalitis vaccine (Nakayama-NIH strain) in Korea
por: Lee, Sunmi, et al.
Publicado: (2016)

Debate: Are surrogate end-point studies worth the effort?
por: Valabhji, Jonathan, et al.
Publicado: (2000)

Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022)

Surrogate endpoints and competing risk of death in cardiac arrest research
por: McCredie, Victoria A., et al.
Publicado: (2016)

Protein C as a surrogate end-point for clinical trials of sepsis
por: Liu, Kathleen D, et al.
Publicado: (2008)

Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression
por: Kontos, Christos K.
Publicado: (2015)

Re-examining ethical obligations in the intensive care unit: HIV disclosure to surrogates
por: Vernillo, Anthony T, et al.
Publicado: (2007)

Pulse rate variability: a new biomarker, not a surrogate for heart rate variability
por: Yuda, Emi, et al.
Publicado: (2020)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
por: Gill, Jennifer, et al.
Publicado: (2019)

Commentary: Fast and accurate surrogate of finite-element analysis: For bench to bedside, we need it now!
por: Wisneski, Andrew D., et al.
Publicado: (2020)

Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Surrogate end points of quality of life assessment: have we really found what we are looking for?
por: Tassinari, Davide
Publicado: (2003)

A randomised controlled trial is not a pilot trial simply because it uses a surrogate endpoint
por: Campbell, M. J., et al.
Publicado: (2018)

Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
por: Austin, R. Marshall, et al.
Publicado: (2020)

Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
por: Aniwan, Satimai
Publicado: (2022)

Flux-sum analysis identifies metabolite targets for strain improvement
por: Lakshmanan, Meiyappan, et al.
Publicado: (2015)

Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Noninvasive surrogates of intracranial pressure: another piece added with magnetic resonance imaging of the cerebrospinal fluid thickness surrounding the optic nerve
por: Geeraerts, Thomas
Publicado: (2013)

Respiratory variation in inferior vena cava diameter: surrogate of central venous pressure or parameter of fluid responsiveness? Let the physiology reply
por: Bodson, Laurent, et al.
Publicado: (2012)

The feasibility of CT lung volume as a surrogate marker of donor–recipient size matching in lung transplantation
por: Jung, Woo Sang, et al.
Publicado: (2016)

Drug Resistance and Evolvability in an Emerging Human Fungal Pathogen
por: Billmyre, R. Blake
Publicado: (2022)

Phosphorylation of STAT3 and ERBB2 mediates hypoxia-induced VEGF release in ARPE-19 cells
por: Hwang, Soohyun, et al.
Publicado: (2020)

Balancing between prejudice and fact for Gaming Disorder: Does the existence of alcohol use disorder stigmatize healthy drinkers or impede scientific research?: Commentary on “Scholars’ open debate paper on the World Health Organization ICD-11 Gaming Disorder proposal”
por: Lee, Seung-Yup, et al.
Publicado: (2017)

Gaps in the implementation of COVID-19 mitigation measures could lead to development of new strains of antimicrobial resistant pathogens: Nigerian perspective
por: Yusuf, Ibrahim, et al.
Publicado: (2021)

Puzzle of highly pathogenic human coronaviruses (2019-nCoV)
por: Li, Jing, et al.
Publicado: (2020)

Recurrent copy number variations in the human fungal pathogen Candida parapsilosis
por: Selmecki, Anna
Publicado: (2023)

Increasing prediction accuracy of pathogenic staging by sample augmentation with a GAN
por: Kwon, ChangHyuk, et al.
Publicado: (2021)

Comparative genome analysis of Korean field strains of infectious laryngotracheitis virus
por: La, Tae-Min, et al.
Publicado: (2019)

Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in Koreans
por: Kim, Jong-Dai, et al.
Publicado: (2017)

Experience of Endoscopists in Endoscopic Retrograde Cholangiopancreatography in Surgically Altered Anatomy Patients
por: Park, Chang-Hwan
Publicado: (2020)

Caudwell Xtreme Everest: a field study of human adaptation to hypoxia
por: Grocott, Mike, et al.
Publicado: (2007)

Indoor air as a vehicle for human pathogens: Introduction, objectives, and expectation of outcome
por: Sattar, Syed A.
Publicado: (2016)

Pathotyping avian pathogenic Escherichia coli strains in Korea
por: Jeong, Yong-Wun, et al.
Publicado: (2012)

Origin of XMRV and its Demise as a Human Pathogen Associated with Chronic Fatigue Syndrome
por: Hohn, Oliver, et al.
Publicado: (2011)

Workshop on “The Role of Indoor Air as a Vehicle for Human Pathogens”: A Panel Discussion
por: Sattar, Syed A.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_74hpq6gkqmnn1vn3a2948uktbs